Kramer Robin sold BIIB
February 16, 2024 · Form 4 insider transaction
Kramer Robin sold 269 shares of Biogen Inc. at $219.08 per share, a transaction worth $58.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
269
Price
$219.08
Total value
$58.9K
InsiderKramer Robin
Role—
CompanyBiogen Inc. (BIIB)
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 16, 2024
Filing dateFebruary 21, 2024
Shares owned after5,923
OwnershipDirect
10b5-1 planNo
AmendedNo